XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2024
Stockholders’ Equity [Line Items]  
Schedule of Warrant and Stock Option Grants with Time-Based Vesting The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the six months ended June 30, 2024 were:
   Warrant Grants   Stock Option Grants   Restricted
Stock
Units		 
   Number of
shares
subject to
warrants		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
options		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
restricted
stock units		 
Balance at December 31, 2023   11,394   $58.72    3,333   $39.60    165,663 
Granted   
-
    
-
    
-
    
-
    88,362 
Exercised   
-
    
-
    
-
    
-
    (90,029)
Cancelled/Expired   (2,293)   53.64    
-
    
-
    
-
 
Balance at June 30, 2024   9,101   $60.00    3,333   $39.60    163,996 
Exercisable at June 30, 2024   9,101   $60.00    3,333   $39.60    163,996 
The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the six months ended June 30, 2023 were:
   Warrant Grants   Stock Option Grants   Restricted
Stock
Units		 
   Number of
shares
subject to
warrants		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
options		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
restricted
stock units		 
Balance at December 31, 2022   104,515   $20.25    7,889   $48.75    160,650 
Granted   -    -    
-
    
-
    32,736 
Exercised   (54,872)   9.75    
-
    
-
    (25,269)
Cancelled/Expired   (2,974)   137.10    (959)   101.25    
-
 
Balance at June 30, 2023   46,669   $25.05    6,930   $41.40    168,117 
Exercisable at June 30, 2023   46,669   $25.05    6,930   $41.40    168,117 
Schedule of Stock-Based Compensation Expense Stock-based compensation expense for three and six months ended June 30, 2024 is 2023 was as follows:
   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
Stock-based compensation expense  $
    -
   $147,873   $
     -
   $295,746 
Warrant [Member]  
Stockholders’ Equity [Line Items]  
Schedule of Company’s Outstanding Warrants and Options The Company’s outstanding warrants and options at June 30, 2024 are as follows:
Warrants Outstanding   Warrants Exercisable 
Exercise Price
Range		   Number
Outstanding		   Weighted Average
Remaining
Contractual Life
(in years)		   Weighted
Average
Exercise 
Price		   Number
Exercisable		   Weighted
Average
Exercise Price		   Intrinsic Value 
$60.00    9,101    1.51   $60.00    9,101   $60.00    
      -
 
Options Outstanding   Options Exercisable 
Exercise Price
Range		   Number
Outstanding		   Weighted Average
Remaining
Contractual Life
(in years)		   Weighted
Average
Exercise
Price		   Number
Exercisable		   Weighted
Average
Exercise Price		   Intrinsic Value 
$39.60    3,333    0.41   $39.60    3,333   $39.60    
      -